PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 273 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 3.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $235,837 | -12.3% | 7,687 | +52.2% | 0.00% | – |
| Q3 2022 | $269,000 | -4.9% | 5,049 | +3.9% | 0.00% | – |
| Q2 2022 | $283,000 | -27.8% | 4,859 | -5.3% | 0.00% | – |
| Q1 2022 | $392,000 | +56.2% | 5,130 | +23.1% | 0.00% | – |
| Q4 2021 | $251,000 | +10.1% | 4,168 | +2.4% | 0.00% | – |
| Q3 2021 | $228,000 | -83.3% | 4,070 | -79.0% | 0.00% | -100.0% |
| Q2 2015 | $1,367,000 | -17.5% | 19,336 | +3.7% | 0.00% | 0.0% |
| Q1 2015 | $1,656,000 | +12.4% | 18,639 | +12.2% | 0.00% | 0.0% |
| Q4 2014 | $1,473,000 | -7.0% | 16,609 | -3.7% | 0.00% | 0.0% |
| Q2 2014 | $1,584,000 | -87.6% | 17,245 | -90.6% | 0.00% | -83.3% |
| Q1 2014 | $12,775,000 | +29.4% | 182,525 | +6.3% | 0.01% | +20.0% |
| Q4 2013 | $9,872,000 | -67.7% | 171,725 | -72.9% | 0.01% | -68.8% |
| Q3 2013 | $30,528,000 | +12.7% | 634,820 | -32.0% | 0.02% | +6.7% |
| Q2 2013 | $27,078,000 | – | 933,720 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Key Colony Management, LLC | 134,600 | $13,045,000 | 11.31% |
| Biondo Investment Advisors, LLC | 279,717 | $27,110,000 | 8.33% |
| GILDER GAGNON HOWE & CO LLC | 3,177,130 | $307,927,000 | 4.48% |
| DARUMA CAPITAL MANAGEMENT LLC | 814,470 | $78,938,000 | 3.47% |
| MAGEE THOMSON INVESTMENT PARTNERS LLC | 126,022 | $12,214,000 | 3.01% |
| NEXT CENTURY GROWTH INVESTORS LLC | 768,396 | $74,472,000 | 2.63% |
| MARXE AUSTIN W & GREENHOUSE DAVID M | 180,000 | $17,446,000 | 2.38% |
| Lisanti Capital Growth, LLC | 48,280 | $4,679,000 | 2.35% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 79,017 | $7,658,000 | 2.00% |
| Atika Capital Management LLC | 21,500 | $2,084,000 | 1.60% |